Try it
Pharmacology · Drugs in pregnancy: atenolol and fetal growth
Sample itemA woman with chronic hypertension asks which beta-blocker should be avoided during pregnancy because prolonged exposure is associated with fetal growth restriction. Which one is it?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. Atenolol
Prolonged atenolol use in pregnancy has been associated with reduced birth weight and fetal growth restriction, and beta-blockade can cause neonatal bradycardia and hypoglycaemia. Labetalol, methyldopa and nifedipine are the usual antihypertensives in pregnancy.
Option by option
A. Atenolol (correct)
Correct. Atenolol is associated with fetal growth restriction.
B. Methyldopa
Methyldopa has a long safety record in pregnancy.
C. Nifedipine
Nifedipine is an accepted antihypertensive in pregnancy.
D. Labetalol
Labetalol is a commonly chosen antihypertensive in pregnancy.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?